Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Huons Co., Ltd. (243070:KRX), powered by AI.
Huons Co., Ltd. is currently trading at ₩28,800. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Huons Co., Ltd. on Alpha Lenz.
Huons Co., Ltd.'s P/E ratio is 8.3.
“Huons Co., Ltd. trades at a P/E of 8.3 (undervalued) with solid ROE of 11.9%.”
Ask for details →Huons Co., Ltd. is a distinguished biotechnology and pharmaceutical company headquartered in South Korea, primarily focused on the development, manufacture, and distribution of medical products and healthcare solutions. With a robust portfolio, Huons specializes in producing a diverse range of pharmaceuticals, including prescription drugs, over-the-counter products, and specialty remedies. The company plays a significant role in the healthcare sector by providing state-of-the-art medical equipment and cosmeceuticals, catering to both domestic and international markets. Huons is renowned for its commitment to innovation and quality, employing advanced research and development to enhance its product efficacy and safety. The company's impact spans across various sectors, including hospitals, clinics, and consumer health markets, aligning itself with the broader goals of improving health outcomes and access to reliable medical treatments. As a key player in the global pharmaceutical industry, Huons contributes significantly to medical advancements and healthcare delivery, reflecting its corporate mission of enhancing life quality through better healthcare solutions. Its strategic expansion and partnerships in multiple regions underline its market significance and commitment to growth and excellence in the biotech field.
“Huons Co., Ltd. trades at a P/E of 8.3 (undervalued) with solid ROE of 11.9%.”
Ask for details →Huons Co., Ltd. (ticker: 243070) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 912 employees. Market cap is $352.8B.
The current price is ₩28,800 with a P/E ratio of 8.27x and P/B of 0.94x.
ROE is 11.85% and operating margin is 7.35%. Annual revenue is $620.8B.